K7A1E7 (K7A1E7_PANTR) Pan troglodytes (Chimpanzee)
Protein-serine/threonine kinase UniProtKBInterProSTRINGInteractive Modelling
407 aa; Sequence (Fasta) ;
12 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
33 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PS2 | homo-2-mer | 2×TLA; 2×PV2; | ||||
Assess | ||||||
Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PS10 | homo-2-mer | 2×PV0; 2×TLA; | ||||
Assess | ||||||
Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PA7 | homo-2-mer | 2×PFT; 2×TLA; | ||||
Assess | ||||||
Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PS8 | homo-2-mer | 2×PV8; 2×TLA; | ||||
Assess | ||||||
Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PS35 | homo-2-mer | 2×TLA; 2×P35; | ||||
Assess | ||||||
Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PA1 | homo-2-mer | 2×PV1; 2×TLA; | ||||
Assess | ||||||
crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic … | homo-2-mer | |||||
Assess | ||||||
crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic … | homo-2-mer | 2×TF1; | ||||
Assess | ||||||
crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic … | homo-2-mer | 2×TF3; | ||||
Assess | ||||||
crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic … | homo-2-mer | 2×TF2; | ||||
Assess | ||||||
crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic … | homo-2-mer | 2×ATP; 2×TF1; 2×MG; | ||||
Assess | ||||||
Crystal structure of human PDK2 complexed with GM10030 | homo-2-mer | 2×SO4; 1×GOL; 2×EH0; | ||||
Assess | ||||||
Crystal structure of human PDK2 complexed with GM67520 | homo-2-mer | 3×GOL; 4×SO4; 2×EH3; | ||||
Assess | ||||||
crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic … | homo-2-mer | 2×ADP; 2×MG; 2×TF4; | ||||
Assess | ||||||
Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PS46 | homo-2-mer | 2×P46; | ||||
Assess | ||||||
VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupt… | homo-2-mer | 2×TF3; 4×MG; 2×7TJ; | ||||
Assess | ||||||
VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupt… | homo-2-mer | 2×TF3; 2×MG; 2×SZ6; | ||||
Assess | ||||||
Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 5 | homo-2-mer | 2×CL; 6×ACT; 4×DMS; 2×6I4; | ||||
Assess | ||||||
Crystal structure of human PDK2 complexed with an allosteric inhibitor compound 8c | homo-2-mer | 2×FLC; 3×PEG; 1×GOL; 1×SO4; 2×EGX; | ||||
Assess | ||||||
Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 13 | homo-2-mer | 2×CL; 4×ACT; 4×DMS; 2×J0F; | ||||
Assess | ||||||
Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 2 | homo-2-mer | 2×CL; 4×ACT; 4×DMS; 2×42A; | ||||
Assess | ||||||
Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 7 | homo-2-mer | 5×ACT; 4×DMS; 2×67V; 1×CL; | ||||
Assess | ||||||
Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 1 | homo-2-mer | 2×CL; 4×ACT; 4×DMS; 2×W6P; | ||||
Assess | ||||||
Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 20 | homo-2-mer | 2×CL; 2×ACT; 4×DMS; 2×5ZP; | ||||
Assess | ||||||
Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures | monomer | 1×TF3; 1×NL8; 1×DMS; 1×CL; | ||||
Assess | ||||||
Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures | monomer | 1×MG; 1×NN8; 1×TF3; | ||||
Assess | ||||||
Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures | monomer | 1×TF3; 1×NMW; 1×DMS; | ||||
Assess | ||||||
Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures | monomer | 1×TF3; 1×NLZ; 1×DMS; 1×CL; | ||||
Assess | ||||||
Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures | monomer | 1×TF3; 1×MG; 1×NN8; | ||||
Assess | ||||||
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate… | monomer | 1×7FE; 1×TF3; 2×CL; | ||||
Assess | ||||||
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate… | monomer | 1×7FW; 1×TF3; 3×CL; | ||||
Assess | ||||||
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate… | monomer | 1×TF3; 1×7F9; 1×MG; | ||||
Assess | ||||||
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate… | monomer | 1×7FV; 1×TF3; 4×CL; | ||||
Assess |
2 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
2q8f.1.B | homo-2-mer | 0.84 | 69.90 | |||
Assess | ||||||
1jm6.1.A | homo-2-mer | 0.81 | 1×MG; 2×ADP; | 97.54 | ||
Assess |